Has Cori Daines received payments from drug or device companies?

Yes. Drug and device makers reported $27,371 in general payments to Cori Daines across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cori Daines did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cori Daines come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cori Daines

Pediatric Pulmonology · Tucson, AZNPI 1285715417

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $26,250 of the $27,371 with a category attached, or 95.9%. Vertex accounts for 96.3% of it on its own, with 6 other manufacturers making up the rest. 2024 is the largest year on record at $26,250, more than ten times the $651 reported in 2019. Among pediatric pulmonology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,371in general payments, 2019–2025

Across 39 payments — averaging $701.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vertex$26K
AstraZeneca$360
Chiesi USA, Inc.$306
Philips North America LLC$149
Advanced Respiratory, Inc$98
Sanofi$72
plus $15 from 1 others

$2,529,649in research payments, 2019–2025

Across 57 payments — averaging $44,380 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vertex$2.5M
Janssen Research & Development, LLC$15K
AbbVie$4K
Boehringer Ingelheim International GmbH$2K
Vivus LLC$392

What the payments were for

Consulting fees$26,25096%
Food & beverage$9303%
Education$1921%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vertex	2	$26,372
AstraZeneca	3	$360
Chiesi USA, Inc.	21	$306
Philips North America LLC	10	$149
Advanced Respiratory, Inc	1	$98
Sanofi	1	$72
Baxter Healthcare	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FASENRA$125

How this compares

$27,371 in reported general payments places this provider in the 95th percentile of 20 pediatric pulmonology providers in Arizona.

See all pediatric pulmonology providers in Arizona →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AlvescoCiclesonide	12	$3,335
Fluticasone Propionate	15	$171
Montelukast Sodium	15	$128

Paid to pharmacies, not to this prescriber.

Other pediatric pulmonology in Tucson

Wayne MorganTucson$4K
Fernando MartinezTucson$2K
Chiarina GalvezTucson$443
Rees LeeTucson$76
Kelvin PanesarScottsdale$9K
Gregory LegrisPhoenix$8K
Rajeev BhatiaPhoenix$6K
Edward CarterPhoenix$3K
Rupali DrewekPhoenix$3K
Michelle RatkiewiczPhoenix$2K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →